Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Psychiatry
  • Psychiatry Cases
  • Liraglutide-Associated...

Liraglutide-Associated Depression in Type 2 Diabetes Patient: Case Report Raises Concerns

Written By : Medha Baranwal |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-06-07T09:00:45+05:30  |  Updated On 7 Jun 2024 9:01 AM IST
Men with type 1 diabetes at elevated risk of depressive symptoms
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

China: A recent case report has drawn attention to a potential association between liraglutide, a commonly prescribed medication for type 2 diabetes, and the development of depression in patients. The report, published in Medicine Journal, highlights the need for heightened awareness and monitoring of mental health symptoms in individuals undergoing treatment with this medication.

Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) widely used to improve glycemic control and aid weight loss in patients with type 2 diabetes (T2D). While it has demonstrated efficacy in lowering blood sugar levels and promoting weight loss, concerns have emerged regarding its potential psychiatric side effects, particularly depression.

The case report documents the experience of a patient with type 2 diabetes who developed symptoms of depression shortly after initiating treatment with Liraglutide for glycemic control and weight reduction. Symptoms included irritability, poor mood, progressing to sadness, decreased interest and energy, physical discomfort, and low self-esteem. A clinical diagnosis of a depressive episode was made, coinciding with the initiation of liraglutide.

The patient, a 39-year-old male with a graduate degree and employed as a company staff member, was admitted to the hospital on December 4, 2023, due to “poor mood for over two months.” Two months before admission, the patient was diagnosed with T2D at another hospital and was prescribed Liraglutide 0.6 mg subcutaneous injection once daily (qd) and Dapagliflozin 10 mg qd for blood sugar control and weight loss

Subsequently, he began to experience symptoms of mood deterioration, primarily characterized by irritability, inexplicable sadness, decreased energy, and loss of interest. After two weeks, the liraglutide dose was increased to 1.8 mg qd during a follow-up visit at the same hospital due to insignificant weight loss.

Under the treatment with Dapagliflozin and Liraglutide, the patient lost approximately 20 kg over 2 months.

Regarding treatment, the patient continued his previous regimen for diabetes and hypertension. In terms of psychiatric treatment, he was initially prescribed Escitalopram Oxalate 10 mg qd and Alprazolam 0.4 mg every night to improve sleep and mood. After one week of medication, the patient reported an improvement in mood. To further improve symptoms, the doctors increase the dose of Escitalopram Oxalate to 20 mg qd.

On the day of discharge, the patient reported significant improvement in mood, regaining control over his life, feeling calm and relaxed, good appetite, resuming outdoor activities, and better sleep quality. At discharge, the patient's Hamilton Depression Scale score was 6, suggesting no depressive symptoms, and Hamilton Anxiety Scale score was 5, suggesting no anxiety symptoms. A 2-week follow-up showed that the patient's mood remained stable.

The report by Yiming Wang, Department of Psychiatry, Affiliated Hospital of Guizhou Medical University, Guiyang, China, and colleagues explores potential mechanisms, such as GLP-1RA effects on glucose fluctuations and dopamine modulation, which might lead to depressive symptoms. The impact on the brain reward system and the reduction in cravings for addictive substances after GLP-1RA use is also discussed as a factor in mood regulation.

In conclusion, the case report contributes to the growing body of literature on the psychological side effects of GLP-1RAs, calling for a balanced approach to patient care that encompasses both mental and physical health considerations. As the use of these agents expands, clinicians should be aware of the potential psychological impacts and ensure comprehensive monitoring and management strategies for their patients.

"Future research should focus on elucidating the neuropsychological mechanisms of GLP-1RAs and exploring the potential risks and benefits in patients with preexisting mood disorders," the researchers wrote.

Reference:

He, Yangliuqing MDa; Liang, Fenrong MDa; Wang, Yiming PhDa,b,*; Wei, Yuhan MDa; Ma, Tianpei MDa. Liraglutide-associated depression in a patient with type 2 diabetes: A case report and discussion. Medicine 103(18):p e37928, May 03, 2024. | DOI: 10.1097/MD.0000000000037928


Medicine journaldepressionGLP-1 receptor agonistsliraglutidetype 2 diabetes
Source : Medicine journal
Medha Baranwal
Medha Baranwal

    MSc. Biotechnology

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Darbapoetin Alfa In Chemotherapy Induced Anaemia: Check out 5 takeaways from recent study

    Darbapoetin Alfa In Chemotherapy Induced Anaemia: Check out 5 takeaways from recent study

    Biosimilar Denosumab of Alkem (Denuril) shows Comparable Efficacy in Treating Postmenopausal Osteoporosis in Indian Women

    Biosimilar Denosumab of Alkem (Denuril) shows Comparable Efficacy in Treating Postmenopausal...

    View All

    Journal Club Today

    Medical Journalism: Need of the Hour - Ft: Dr Prem Aggarwal (Chairman, Medical Dialogues), Dr Nandita Mohan (Head, MDTV Division, Medical Dialogues)

    Medical Journalism: Need of the Hour - Ft: Dr Prem Aggarwal (Chairman, Medical Dialogues), Dr...

    View All

    Health News Today

    Health Bulletin 08/ May/ 2025

    Health Bulletin 08/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok